Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations
Biology of Blood and Marrow Transplantation · 2020-06 · 26 (6) · 1124-1130
DOI: 10.1016/j.bbmt.2020.02.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-06. Verfasst von Inga Hofmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts; Department of Pathology, Boston Children's Hospital, Boston, …. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts. Electronic address: ihofmann@wisc.edu.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Hofmann, I., Avagyan, S., Stetson, A., Guo, D., Al-Sayegh, H., London, W. B., & Lehmann, L. (2020). Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations. Biology of Blood and Marrow Transplantation, 26(6), 1124-1130. https://doi.org/10.1016/j.bbmt.2020.02.015
Vancouver
Hofmann I, Avagyan S, Stetson A, Guo D, Al-Sayegh H, London WB, et al. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations. Biology of Blood and Marrow Transplantation. 2020;26(6):1124-1130. doi:10.1016/j.bbmt.2020.02.015
BibTeX
@article{Hofmann2020,
author = {Hofmann, Inga and Avagyan, Serine and Stetson, Alyssa and Guo, Dongjing and Al-Sayegh, Hasan and London, Wendy B and Lehmann, Leslie},
title = {Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations},
journal = {Biology of Blood and Marrow Transplantation},
year = {2020},
volume = {26},
number = {6},
pages = {1124--1130},
doi = {10.1016/j.bbmt.2020.02.015}
}
EUVIMED